Preserving Strong Patents to Ensure Investment in New Therapies
At a time when we need to be creating incentives for investment in innovative therapies, Congress is considering patent reform legislation that could make future advances in treating epilepsy all too rare. A strong and secure patent system that encourages investments in innovative treatments and devices is critical for the millions of Americans waiting for breakthrough therapies and a cure to live their lives to their fullest potential.
Patient Community Supports a Strong Patent System
On September 8, 2015, the Epilepsy Foundation and a diverse group of more than 100 national and state-based advocacy organizations sent a letter to the House and Senate Judiciary Committees urging Congress to amend H.R. 9 to preserve the highly-detailed and sophisticated systems designed by Hatch-Waxman and BPCIA and avoid weakening the patents that sustain medical research. Read the letter here.